Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
Big Ten Cancer Research Consortium
Big Ten Cancer Research Consortium
University Health Network, Toronto
University of Chicago
Sun Yat-sen University
Palo Alto Veterans Institute for Research
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Alliance Foundation Trials, LLC.
Memorial Sloan Kettering Cancer Center
Wake Forest University Health Sciences
UNC Lineberger Comprehensive Cancer Center
Fundación GECP
Henry Ford Health System
China Medical University, China
PrECOG, LLC.
Nantes University Hospital
Centre Antoine Lacassagne
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
University of Maryland, Baltimore
Shanghai Pulmonary Hospital, Shanghai, China
Groupe Francais De Pneumo-Cancerologie
Cedars-Sinai Medical Center
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
Anhui Provincial Cancer Hospital
University of Colorado, Denver
Copernicus Memorial Hospital
Fudan University
Addario Lung Cancer Medical Institute
Shanghai Chest Hospital of Shanghai Jiao Tong University
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Emory University
UNC Lineberger Comprehensive Cancer Center
NYU Langone Health
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
UNICANCER
AHS Cancer Control Alberta
Medical University of South Carolina
Fox Chase Cancer Center
University College, London
Stanford University
Oncology Center of Biochemical Education And Research
Peking University Cancer Hospital & Institute
AIO-Studien-gGmbH
Aalborg University Hospital
Regina Elena Cancer Institute
Sichuan University
China Medical University, China
Second Affiliated Hospital, School of Medicine, Zhejiang University